Novel Biologic for Sjogren's Clears Penultimate Hurdle

(MedPage Today) — CHICAGO — An investigational biologic against B-cell activating factor (BAFF) was effective in treating Sjögren’s disease in twin phase III trials, a researcher reported here, although salivation was not improved…